Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions

Bronchiolitis obliterans syndrome (BOS) may develop after either lung or haematopoietic stem cell transplantation (HSCT), with similarities in histopathological features and clinical manifestations. However, there are differences in the contributory factors and clinical trajectories between the two...

Descripción completa

Detalles Bibliográficos
Autores principales: Glanville, Allan R., Benden, Christian, Bergeron, Anne, Cheng, Guang-Shing, Gottlieb, Jens, Lease, Erika D., Perch, Michael, Todd, Jamie L., Williams, Kirsten M., Verleden, Geert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309343/
https://www.ncbi.nlm.nih.gov/pubmed/35898810
http://dx.doi.org/10.1183/23120541.00185-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309343/
https://www.ncbi.nlm.nih.gov/pubmed/35898810
http://dx.doi.org/10.1183/23120541.00185-2022

Ejemplares similares